RANKL immunisation inhibits prostate cancer metastasis by modulating EMT through a RANKL-dependent pathway
Abstract Prostate cancer (PCa) morbidity in the majority of patients is due to metastatic events, which are a clinical obstacle. Therefore, a better understanding of the mechanism underlying metastasis is imperative if we are to develop novel therapeutic strategies. Receptor activator of nuclear fac...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/af65c06b2e6b4f5390c60c729a4c4302 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|